Evidence map›Paper›PMID 24332150›Full record

ArticleAmerican heart journal2014

Gene-environment interaction between SCN5A-1103Y and hypokalemia influences QT interval prolongation in African Americans: the Jackson Heart Study.

Ermeg L Akylbekova, John P Payne, Christopher Newton-Cheh, Warren L May, Ervin R Fox, James G Wilson, Daniel F Sarpong, Herman A Taylor, Joseph F Maher

Abstract read
In one paragraph

Article in American heart journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. A novel gain-of-function mutationAmerican journal of cardiovascular disease · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Predictive Value of TFrontiers in physiology · 2018
    Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Ermeg L AkylbekovaJackson Heart Study, Jackson State University, Jackson, MS.
John P PayneG.V. (Sonny) Montgomery Veterans Affairs Medical Center, Jackson, MS.
Christopher Newton-ChehCardiolovascular Research Center and Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA.
Warren L MayDepartments of Biostatistics and Bioinformatics, University of Mississippi Medical Center, Jackson, MS.
Ervin R FoxMedicine, University of Mississippi Medical Center, Jackson, MS.
James G WilsonPhysiology and Biophysics, University of Mississippi Medical Center, Jackson, MS.
Daniel F SarpongJackson Heart Study, Jackson State University, Jackson, MS.
Herman A TaylorJackson Heart Study, Jackson State University, Jackson, MS; Medicine, University of Mississippi Medical Center, Jackson, MS.
Joseph F MaherMedicine, University of Mississippi Medical Center, Jackson, MS; Cancer Institute, University of Mississippi Medical Center, Jackson, MS. Electronic address: jmaher@umc.edu.
University of Mississippi Medical Center · USJackson State University · USG.V. (Sonny) Montgomery VA Medical Center · USMassachusetts General Hospital · US

Funding

PHARMACOGENOMICS OF ARRHYTHMIA THERAPYU01HL065962 · NHLBI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2001 to 2009
$24.8M
Understanding Obesity In Relation to the Built EnvironmentP20MD006899 · NIMHD · JACKSON STATE UNIVERSITY · PI ANTOINE-LAVIGNE, DONNA A · 2012 to 2016
$5.3M
JACKSON HEART STUDY--EXAM CENTERN01HC095171 · HC · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI JONES, DANIEL W · 1999 to 2001
$4.6M
JACKSON HEART STUDY--TRAINING CENTERN01HC095172 · HC · TOUGALOO COLLEGE · PI SRINIVASAN, ASOKA · 1999 to 2001
$516k
Development of a humanized anti-CD47 antibody for treatment of tissue ischemia.R41HL095172 · NHLBI · VASCULOX, INC. · PI FRAZIER, WILLIAM A · 2009 to 2009
$198k
JACKSON HEART STUDY-N01HC95170N01HC095170 · HC · JACKSON STATE UNIVERSITY · PI TAYLOR, HERMAN ALFRED · 1999 to 2006
$20k
NHLBI NIH HHS N01 HC095170NHLBI NIH HHS N01 HC095171NHLBI NIH HHS N01 HC095172NHLBI NIH HHS U01 HL065962NIMHD NIH HHS P20 MD006899
6 · The paper itself

Abstract

backgroundAfrican-American ancestry, hypokalemia, and QT interval prolongation on the electrocardiogram are all risk factors for sudden cardiac death (SCD), but their interactions remain to be characterized. SCN5A-1103Y is a common missense variant, of African ancestry, of the cardiac sodium channel gene. SCN5A-1103Y is known to interact with QT-prolonging factors to promote ventricular arrhythmias in persons at high risk for SCD, but its clinical impact in the general African-American population has not been established.

methodsWe genotyped SCN5A-S1103Y in 4,476 participants of the Jackson Heart Study, a population-based cohort of African Americans. We investigated the effect of SCN5A-1103Y, including interaction with hypokalemia, on QT interval prolongation, a widely-used indicator of prolonged myocardial repolarization and predisposition to SCD. We then evaluated the two sub-components of the QT interval: QRS duration and JT interval.

resultsThe carrier frequency for SCN5A-1103Y was 15.4%. SCN5A-1103Y was associated with QT interval prolongation (2.7 milliseconds; P < .001) and potentiated the effect of hypokalemia on QT interval prolongation (14.6 milliseconds; P = .02). SCN5A-1103Y had opposing effects on the two sub-components of the QT interval, with shortening of QRS duration (-1.5 milliseconds; P = .001) and prolongation of the JT interval (3.4 milliseconds; P < .001). Hypokalemia was associated with diuretic use (78%; P < .001).

conclusionsSCN5A-1103Y potentiates the effect of hypokalemia on prolonging myocardial repolarization in the general African-American population. These findings have clinical implications for modification of QT prolonging factors, such as hypokalemia, in the 15% of African Americans who are carriers of SCN5A-1103Y.

Indexed as

Gene-Environment InteractionAdultAgedAllelesBlack or African AmericanDeath, Sudden, CardiacElectrocardiographyFemaleGenetic Predisposition to DiseaseHeart Conduction SystemHumansHypokalemiaMaleMiddle AgedNAV1.5 Voltage-Gated Sodium ChannelNAV1.5 Voltage-Gated Sodium ChannelSCN5A protein, human

Identifiers

PMID24332150
PMCPMC3884587
OpenAlexW2000129904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.